HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by article Browse by volume    

Heroin Addiction and Related Clinical Problems: 2015, 17, 2-3 (pages: 9 - 16)

The Level of Readiness for HCV treatment among infected drug users at the centre for prevention and treatment of drug addicts in Celje, Slovenia

Gabrovec B.

Summary: Introduction: Drug users, especially intravenous drug users, are those who experience the highest risk of HCV and HIV infection. A high prevalence of hepatitis C (HCV) has been observed among drug users; however, the number of users who decide to enter treatment remains low. Aims: The goal of the present study has been to establish the prevalence of HCV among drug users receiving OST (Opioid Substitution Therapy), while collecting drug users' thoughts on the matter, as well as their awareness and knowledge of HCV. Results: The results show a high prevalence of HCV (45%) and a lack of knowledge about HCV infection and treatment among drug users receiving OST, which is a result of the unavailability of relevant information. Conclusion: A systematic approach to raising awareness and enhancing the provision of information about HCV infection and treatment to patients receiving OST is now required.

 

EUROPAD - European Opiate Addiction Treatment Association
Brussels, Belgium, EU
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page